InVivo Therapeutics Holdings Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 2.310 million compared to USD 2.195 million a year ago. Net loss was USD 2.309 million compared to USD 2.189 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.49 a year ago. For the half year, operating loss was USD 4.534 million compared to USD 4.623 million a year ago. Net loss was USD 4.532 million compared to USD 4.603 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 1.7 a year ago.